Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Biosciences Announces Dose Escalation Initiation of the Phase I Trial of Pidnarulex as a Treatment for Advanced Hematological Malignancies 2021-08-25 19:00
Ocumension Acquires all the Equity Interests in Two Ophthalmic Products Mainland China, Further Enhancing its Pipeline Strength 2021-08-25 12:35
GenScript Biotech Reports First Half 2021 Results 2021-08-24 21:38
Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021 2021-08-24 17:04
Hepagene Therapeutics, Inc. Announces Positive Results from Phase I Trial of HPG1860 2021-08-23 22:00
Roche and KeChow Reach a Cooperation Agreement 2021-08-20 23:00
Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics 2021-08-19 21:00
PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases 2021-08-19 20:00
I-Mab Announces Establishment of Environmental, Social and Governance Committee 2021-08-19 19:00
Senhwa's Silmitasertib Receives US FDA Fast Track Designation for the Treatment of Recurrent Sonic Hedgehog Driven Medulloblastoma 2021-08-19 10:57
MicroConstants to Join BioAgilytix Family 2021-08-19 02:30
Henlius reports half-year (H1) 2021 results, outlines remarkable growth in commercialization and needs-driven innovation 2021-08-18 21:35
Holmusk signs agreements with UTHealth and The Harris Center 2021-08-17 21:00
I-Mab to Provide Business and Corporate Updates and Report Financial Results for the Six Months Ended June 30, 2021 on August 31, 2021 2021-08-17 20:00
PharmAbcine to Participate in Biotechgate Digital Partnering 2021-08-17 20:00
Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China 2021-08-17 05:00
111, Inc. Deepens Partnership with Bayer Healthcare 2021-08-16 20:00
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors 2021-08-16 20:00
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19 2021-08-16 15:29
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332 2021-08-16 09:32
1 99 100 101 102 103 165